arrow
K

Katsuya Tsuchihara

National Cancer Center
H指数:49
被引数:8,807

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-agnostic circulating tumor DNA analysis as a comprehensive predictive biomarker of recurrence after ablative radiotherapy for early-stage non-small cell lung cancer

肿瘤非特异性循环肿瘤DNA分析作为早期非小细胞肺癌根治性放疗后复发的综合预测生物标志物

2025-10-010
PRE
Single-cell spatial analysis with Xenium reveals anti-tumour responses of CXCL13 + T and CXCL9+ cells after radiotherapy combined with anti-PD-L1 therapy

Xenium的单细胞空间分析揭示了放疗联合anti-PD-L1治疗后CXCL13 T和CXCL9细胞的抗肿瘤反应

2025-07-160
OA
Spatially resolved gene expression profiling of tumor microenvironment reveals key steps of lung adenocarcinoma development
2024-12-060
OAAI
Landscapes of acquired EGFR and VEGF resistance alterations in colorectal cancer: findings from the PARADIGM biomarker study
2024-03-220
PRE
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

基线ctDNA基因改变可作为转移性结直肠癌帕尼单抗和化疗后生存的生物标志物

2024-02-1213
OAAI
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma

全面的单细胞分析表明,放疗诱导的表达免疫抑制基因的巨噬细胞浸润到食管鳞状细胞癌的肿瘤中

2023-12-159
OAAI
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses
2023-10-261
OAAI
Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways

转座因子通过rig-i介导的病毒感应途径增强放射治疗诱导的细胞免疫反应

2023-08-057
OAAI
Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer

治疗前循环肿瘤DNA检测预测早期非小细胞肺癌大剂量质子束治疗后复发

2023-08-014
PRE
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer A Randomized Clinical Trial

帕尼单抗与贝伐单抗加入标准一线化疗与RAS野生型左侧转移性结直肠癌患者总生存期比较一项随机临床试验

2023-04-1896
OA
Real-world surveillance from cancer patients about their experience of comprehensive genomic profiling tests in Japan
2023-04-040
PRE
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan
2022-12-059
OAAI
Early tumor shrinkage (ETS) and depth of response (DpR) analyses in metastatic colorectal cancer (mCRC) treated with first-line mFOLFOX6 plus panitumumab (PAN) or bevacizumab (BEV): Results from the phase III PARADIGM trial
2022-09-010
OA